Platinum-based compound based on nucleolar stress

A technology of nucleolus stress and compounds, applied in platinum anti-tumor compounds to overcome clinical platinum drug resistance and achieve excellent anti-tumor activity
CN110128477AInactive Publication Date: 2019-08-16TIANJIN MEDICAL UNIV

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
TIANJIN MEDICAL UNIV
Publication Date
2019-08-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a platinum-based compound based on nucleolar stress, wherein the platinum-based compound is a platinum-based antitumor compound formed by carrying out a nitrile-secondary amineClick reaction on cis-monochloro mononitrile diamino platinum and a primary amine-containing RNA polymerase I inhibitor. According to the present invention, the platinum-based antitumor compound hasgood RNA polymerase I inhibitory activity and good tumor selectivity, such that the platinum-based compound has antitumor activity suprior to classical platinum-based drugs, and can reduce toxic-sideeffects and overcome the drug resistance of clinical platinum-based drugs.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of platinum compounds, and more specifically relates to a class of platinum anti-tumor compounds based on nucleolus stress and the research on anti-tumor effect, reduction of toxic and side effects and overcoming clinical platinum drug resistance. Background technique

[0002] Cancer is a major killer that threatens human beings all the time in today's world, and the research on cancer treatment has very far-reaching practical significance. Platinum antineoplastic drugs are an important class of metal chemotherapeutic drugs, which are used in more than half of chemotherapy methods. The representative drug, cisplatin, has a broad anti-tumor spectrum and strong effect, and has synergistic effects with many anti-tumor drugs without cross-resistance. It has remarkable curative effect on ovarian cancer and testicular cancer. cure rate. However, severe adverse reactions (such as myelosuppression, leukopenia, oto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More